DB-OTO Gene Therapy for Inherited Deafness
New England Journal of Medicine · 12.03.2026 · 394 (11) · 1074-1083
DOI: 10.1056/nejmoa2400521 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 12.03.2026. Verfasst von Vassili Valayannopoulos und 34 weiteren Autor:innen. Beteiligte Einrichtung: Regeneron Pharmaceuticals, Tarrytown, NY. Hauptthemen laut MEDLINE: Deafness, Genetic Therapy, Membrane Proteins. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Regeneron Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Regeneron Pharmaceuticals, Tarrytown, NY.
- University of Cambridge, Cambridge, United Kingdom.
- Department of Otolaryngology Head and Neck Surgery, University of California, San Diego, La Jolla.
- Cincinnati Children's Hospital, University of Cincinnati, Cincinnati.
- Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Wauwatosa.
- UCLA School of Medicine, Los Angeles.
ORCID-Profile: Daniela S Carvalho, Lawrence R Lustig
Förderung
- Regeneron Pharmaceuticals
Zitieren
APA
Valayannopoulos, V., Bance, M., Carvalho, D. S., Greinwald, J. H., Harvey, S. A., Ishiyama, A., Landry, E. C., Löwenheim, H., Lustig, L. R., Manrique, M., Nash, R., Polo, R., Pritchett, C. V., Rubinstein, J. T., Shearer, A. E., Del Castillo, I., Anderson, J. J., Corrales, C. E., Quigley, T. M., …, & CHORD Study Group (2026). DB-OTO Gene Therapy for Inherited Deafness. New England Journal of Medicine, 394(11), 1074-1083. https://doi.org/10.1056/nejmoa2400521
Vancouver
Valayannopoulos V, Bance M, Carvalho DS, Greinwald JH, Harvey SA, Ishiyama A, et al. DB-OTO Gene Therapy for Inherited Deafness. New England Journal of Medicine. 2026;394(11):1074-1083. doi:10.1056/nejmoa2400521
BibTeX
@article{Valayannopoulos2026,
author = {Valayannopoulos, Vassili and Bance, Manohar and Carvalho, Daniela S and Greinwald, John H and Harvey, Steven A and Ishiyama, Akira and Landry, Evie C and Löwenheim, Hubert and Lustig, Lawrence R and Manrique, Manuel and Nash, Robert and Polo, Rubén and Pritchett, Cedric V and Rubinstein, Jay T and Shearer, A Eliot and Del Castillo, Ignacio and Anderson, Jeffery J and Corrales, C Eduardo and Quigley, Tera M and Riggs, William J and Weber, Peter and Wilson, Gary and Irvin, Susan C and Hassan, Hazem E and Chen, Yanping and Liu, Rong and Drummond, Meghan C and Sabin, Leah R and Musser, Bret J and Yancopoulos, George D and Kyratsous, Christos A and Herman, Gary A and Baras, Aris and Whitton, Jonathon P and CHORD Study Group, CHORD Study Group},
title = {DB-OTO Gene Therapy for Inherited Deafness},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {11},
pages = {1074--1083},
doi = {10.1056/nejmoa2400521}
}
EUVIMED